Immunocore

Immunocore: Developer of the world’s first approved TCR-therapeutic KIMMTRAK and pioneering a new class of therapeutics to deliver transformative medicines to patients in cancer, infection, and autoimmune. KIMMTRAK generated net revenues of $34M in 2Q22 for patients with metastatic uveal melanoma. Durable clinical activity was presented (ESMO 2022) for PRAME in multiple solid tumors and have initiated four expansion arms.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Marketed, Phase III, Phase l or ll
Disease Space
Anti-infectives, Antivirals, Immuno-Oncology, Immunotherapy, Infectious Disease, Oncology, Rare Disease
Finance
Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
1B +
Therapeutic Modalities
Antibodies, Cell Therapy, Platform Technology
Website:
Profiles:
Address:
Abingdon, Oxfordshire
United Kingdom

Company Participants at Immunocore MAGE-A4 Investor & Analyst Event 2021

  • Bahija Jallal, CEO

Lead Programs

Kimmtrak

Indication Phase
metastatic uveal Melanoma Marketed
Advanced Melanoma 2/3

Top 10 Holders of Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
RTW Investments LP 12.27 5,559,322 283.75 13F 12/31/22
Rock Springs Capital Management LP 7.33 3,321,066 169.51 13F 12/31/22
Baker Bros. Advisors LP 5.56 2,520,731 128.66 13F 12/31/22
Wellington Management Co. LLP 4.75 2,152,966 109.89 13F 12/31/22
Fidelity Management & Research Co. LLC 3.97 1,797,746 91.76 13F 12/31/22
T. Rowe Price Associates, Inc. (Investment Management) 2.94 1,333,916 68.08 13F 12/31/22
Avidity Partners Management LP 2.55 1,154,000 58.90 13F 12/31/22
General Atlantic LLC 2.10 950,000 48.49 13F 12/31/22
Paradigm BioCapital Advisors LP 1.89 857,925 43.79 13F 12/31/22
Pictet Asset Management SA 1.36 618,315 31.56 13F 12/31/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.